Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 16.11 Delayed Data As of Feb 08 |  -0.005 / -0.03%Today’s Change | 12.28 Today|||52-Week Range 16.30 | +3.30% Year-to-Date |
Latest TAK News | Press Releases
| Why Shares of Phathom Pharmaceutical Jumped This Week Jan 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.12 |
| Today’s open | 16.08 |
| Day’s range | 16.08 - 16.17 |
| Volume | 2,372,295 |
| Average volume (3 months) | 3,075,538 |
| Market cap | $48.9B |
Data as of 4:00pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | -42.31% |
| Earnings growth (this year) | +33.87% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +5.34% |
| P/E ratio | 24.2 |
| Price/Sales | 1.42 |
| Price/Book | 1.04 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $31.8B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 6.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
